Clinical Trial Update: Prospective Observational Study on Plerixafor After Chemotherapy

View source ↗

Summary

A completed prospective observational study evaluating the use of Plerixafor after chemotherapy in patients with lymphoma or multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Lymphoma, Myeloma | Status: COMPLETED